Contact
searchSearch
HMP Global

January 2013 - FRMC

Adjustments to Inhaled Corticosteroids in Asthma
01/22/2013
Kristina Woodworth
A study in adults with mild-to-moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy has demonstrated that adjustments in therapy based on biomarkers or symptoms were no better than standard physician...
A study in adults with mild-to-moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy has demonstrated that adjustments in therapy based on biomarkers or symptoms were no better than standard physician...
A study in adults with...
01/22/2013
First Report Managed Care
Pomalidomide in Multiple Myeloma Patients
01/22/2013
Tim Casey
Atlanta—Patients with multiple myeloma who had primary refractory or relapsed and refractory disease had a significant improvement in progression-free and overall survival if they took pomalidomide plus low-dose dexamethasone compared with a...
Atlanta—Patients with multiple myeloma who had primary refractory or relapsed and refractory disease had a significant improvement in progression-free and overall survival if they took pomalidomide plus low-dose dexamethasone compared with a...
Atlanta—Patients with multiple...
01/22/2013
First Report Managed Care
Bendamustine and Rituximab to Treat Mantle Cell Lymphoma
01/22/2013
Tim Casey
Atlanta—A phase 2, single-arm, multicenter study found that patients with mantle cell lymphoma who had received up to 3 prior courses of chemotherapy had an overall response rate of 82% to the combination treatment of bendamustine plus...
Atlanta—A phase 2, single-arm, multicenter study found that patients with mantle cell lymphoma who had received up to 3 prior courses of chemotherapy had an overall response rate of 82% to the combination treatment of bendamustine plus...
Atlanta—A phase 2, single-arm,...
01/22/2013
First Report Managed Care
Lenalidomide for Mantle Cell Lymphoma
01/22/2013
Tim Casey
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle...
01/22/2013
First Report Managed Care
Ruxolitinib and Erythropoiesis-Stimulating Agents for Myelofibrosis
01/22/2013
Tim Casey
Atlanta—A posthoc analysis of a phase 3 study found that patients with myelofibrosis who were receiving erythropoiesis-stimulating agents (ESAs) tolerated the concomitant use of ruxolitinib, a potent janus kinase 1 and 2 inhibitor. The...
Atlanta—A posthoc analysis of a phase 3 study found that patients with myelofibrosis who were receiving erythropoiesis-stimulating agents (ESAs) tolerated the concomitant use of ruxolitinib, a potent janus kinase 1 and 2 inhibitor. The...
Atlanta—A posthoc analysis of a...
01/22/2013
First Report Managed Care
Dabigatran Etexilate and Knee or Hip Replacement Surgery
01/22/2013
Tim Casey
A study found that dabigatran etexilate was effective and well tolerated in patients undergoing total knee or hip replacement surgery.
A study found that dabigatran etexilate was effective and well tolerated in patients undergoing total knee or hip replacement surgery.
A study found that dabigatran...
01/22/2013
First Report Managed Care
AMG 145 Lowers LDL-C in Statin-Intolerant Patients
01/22/2013
Tim Casey
Los Angeles—Patients with high cholesterol who cannot tolerate statins achieved reductions in low-density lipoprotein cholesterol (LDL-C) after taking AMG 145, an investigational drug, according to a global, phase 2, randomized, double-blind,...
Los Angeles—Patients with high cholesterol who cannot tolerate statins achieved reductions in low-density lipoprotein cholesterol (LDL-C) after taking AMG 145, an investigational drug, according to a global, phase 2, randomized, double-blind,...
Los Angeles—Patients with high...
01/22/2013
First Report Managed Care
Daily Intake of Multivitamin Does Not Reduce Risk of Cardiovascular Disease
01/22/2013
Tim Casey
Los Angeles—Male physicians who took a multivitamin every day for more than a decade had similar rates of major cardiovascular events, total myocardial infarction, and total stroke compared with a group that took a placebo, according to a...
Los Angeles—Male physicians who took a multivitamin every day for more than a decade had similar rates of major cardiovascular events, total myocardial infarction, and total stroke compared with a group that took a placebo, according to a...
Los Angeles—Male physicians who...
01/22/2013
First Report Managed Care

Department

News Connection
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
01/22/2013
Kevin L. Carter
Over the years, sources of grafts in allogeneic hematopoietic stem-cell transplantation have evolved from bone marrow to filgrastim-stimulated peripheral blood, which has a much higher content of blood progenitor cells. Several large,...
Over the years, sources of grafts in allogeneic hematopoietic stem-cell transplantation have evolved from bone marrow to filgrastim-stimulated peripheral blood, which has a much higher content of blood progenitor cells. Several large,...
Over the years, sources of...
01/22/2013
First Report Managed Care
Conference Insider
Costs Associated with Acute Coronary Syndrome
01/22/2013
Tim Casey
Los Angeles—A retrospective database analysis of >37,000 claims from employees and their dependents found that patients with acute coronary syndrome (ACS) had high short-term and long-term disability and related costs that are higher or...
Los Angeles—A retrospective database analysis of >37,000 claims from employees and their dependents found that patients with acute coronary syndrome (ACS) had high short-term and long-term disability and related costs that are higher or...
Los Angeles—A retrospective...
01/22/2013
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Headshot of Gary Owens
Interview
An Overview of Vitiligo: Prevalence, Comorbidities, and Available Therapies
05/30/2023
Maria Asimopoulos
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of...
05/30/2023
First Report Managed Care
News
Substantial Annual Health Care Costs Associated With Hemophilia A
06/23/2023
Julie Gould
Researchers conducted a comprehensive literature review to investigate the direct and indirect costs associated with hemophilia A.
Researchers conducted a comprehensive literature review to investigate the direct and indirect costs associated with hemophilia A.
Researchers conducted a...
06/23/2023
First Report Managed Care
News
RSV Vaccination in US Older Adults Could Save Up to $1 Billion Per Season
07/24/2023
Jolynn Tumolo
"Our analysis provides contemporary estimates of the population-level RSV disease burden and insights into the economic value drivers for RSV vaccination," said researchers. 
"Our analysis provides contemporary estimates of the population-level RSV disease burden and insights into the economic value drivers for RSV vaccination," said researchers. 
"Our analysis provides...
07/24/2023
First Report Managed Care
News
Hospital-Onset CDI Incidence, Antibiotic Use Drop With Two-Step Testing
08/16/2023
Jolynn Tumolo
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step...
08/16/2023
First Report Managed Care

January 2013 Volume 10 Issue 1

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use